Our View on 2022: Pharm Exec’s Annual Industry Outlook

A Harvard Business School Healthcare Alumni Association Q&A with Louis Kassa, CEO of the Pennsylvania Biotechnology Center.

Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.

A Q&A with Dr. Zeynep Ton, professor at the MIT Sloan School of Management.

Our milestone 100th episode includes Lisa Henderson, group editorial director; Julian Upton, European and online editor; Fran Pollaro, senior editor; and Andy Studna, associate editor, discussing industry trends in areas such as Chinese biotech, corporate branding, psychedelic medicines, and market access barriers.

Marquez discusses the results of a recent survey about how elements of the industry are reacting to a post remote-work world.

Prescribers cite ways to alleviate systemic threats to their ability to serve.